LACK OF TOLERIZATION OF INTESTINAL MESENCHYMAL AND ENDOTHELIAL CELLS TO BACTERIAL PRODUCTS AND TNF-A: A NOVEL MECHANISM TO SUSTAIN AND AMPLIFY GUT INFLAMMATION

(1) Internal Medicine, Catholic University of Rome, Rome, Italy

(2) Pathobiology, Cleveland Clinic, Cleveland, United States



This item was part of the New approaches to IBD therapy: Stem cells and other agents session at Gastro 2009 UEGW/WCOG London (17th UEGW)

This item can be cited as: Gut 2009; 58 (Suppl II) A11

Categorisation:

  • Format
    • Abstract
  • Language
    • English
  • Year
    • 2009